By Svea Herbst-Bayliss

NEW YORK (Reuters) -Band-Aid and Tylenol maker Kenvue attracted the attention of another activist investor in the second quarter, with Sachem Head Capital Management reporting that it bought into the stock.

Sachem, run by Scott Ferguson, said in a regulatory filing on Thursday that it owned 10.6 million shares in the consumer healthcare company on June 30.

According to the filing, Kenvue was the firm’s fourth biggest holding at the end of the quarter after Twilio, Talen Energy and Seagate Technology Holdings.

Sachem Head declined to comment. The firm is known to quietly push for changes behind the scenes at certain companies, although it mounted a noisy proxy fight at US Foods Holding three years ago.

Kenvue, which was spun out of Johnson & Johnson and now has a

See Full Page